Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy

James J. Peterson, Roger H. Pak, Claude F. Meares

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

A convenient approach to the functionalization of peptides with the macrocyclic 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA) moiety has been developed. Protected components (using tert-butyl or tert-butyloxycarbonyl groups) of both the peptide and the chelate were assembled on the same solid resin support. Deprotection and cleavage of the resin-bound DOTA-peptides were performed in one step using a trifluoroacetic acid cleavage mixture to yield free DOTA-peptide amides.

Original languageEnglish (US)
Pages (from-to)316-320
Number of pages5
JournalBioconjugate Chemistry
Volume10
Issue number2
DOIs
StatePublished - Mar 1999

Fingerprint

Radioimmunotherapy
Solid-Phase Synthesis Techniques
Peptides
Acids
Resins
Trifluoroacetic acid
Trifluoroacetic Acid
Amides
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

ASJC Scopus subject areas

  • Chemistry(all)
  • Organic Chemistry
  • Clinical Biochemistry
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry

Cite this

Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy. / Peterson, James J.; Pak, Roger H.; Meares, Claude F.

In: Bioconjugate Chemistry, Vol. 10, No. 2, 03.1999, p. 316-320.

Research output: Contribution to journalArticle

@article{b3613cf9fa3743d1adf019ae2ad95db3,
title = "Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy",
abstract = "A convenient approach to the functionalization of peptides with the macrocyclic 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA) moiety has been developed. Protected components (using tert-butyl or tert-butyloxycarbonyl groups) of both the peptide and the chelate were assembled on the same solid resin support. Deprotection and cleavage of the resin-bound DOTA-peptides were performed in one step using a trifluoroacetic acid cleavage mixture to yield free DOTA-peptide amides.",
author = "Peterson, {James J.} and Pak, {Roger H.} and Meares, {Claude F.}",
year = "1999",
month = "3",
doi = "10.1021/bc980118t",
language = "English (US)",
volume = "10",
pages = "316--320",
journal = "Bioconjugate Chemistry",
issn = "1043-1802",
publisher = "American Chemical Society",
number = "2",

}

TY - JOUR

T1 - Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy

AU - Peterson, James J.

AU - Pak, Roger H.

AU - Meares, Claude F.

PY - 1999/3

Y1 - 1999/3

N2 - A convenient approach to the functionalization of peptides with the macrocyclic 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA) moiety has been developed. Protected components (using tert-butyl or tert-butyloxycarbonyl groups) of both the peptide and the chelate were assembled on the same solid resin support. Deprotection and cleavage of the resin-bound DOTA-peptides were performed in one step using a trifluoroacetic acid cleavage mixture to yield free DOTA-peptide amides.

AB - A convenient approach to the functionalization of peptides with the macrocyclic 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA) moiety has been developed. Protected components (using tert-butyl or tert-butyloxycarbonyl groups) of both the peptide and the chelate were assembled on the same solid resin support. Deprotection and cleavage of the resin-bound DOTA-peptides were performed in one step using a trifluoroacetic acid cleavage mixture to yield free DOTA-peptide amides.

UR - http://www.scopus.com/inward/record.url?scp=0033104341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033104341&partnerID=8YFLogxK

U2 - 10.1021/bc980118t

DO - 10.1021/bc980118t

M3 - Article

C2 - 10077483

AN - SCOPUS:0033104341

VL - 10

SP - 316

EP - 320

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 2

ER -